| ComPPI: a cellular compartment-specific database for protein–protein interaction network analysis DV Veres, DM Gyurkó, B Thaler, KZ Szalay, D Fazekas, T Korcsmáros, ... Nucleic Acids Research 43 (Database issue (2015)), D485-D493, 2015 | 140 | 2015 |
| Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential mechanism: network models, novel therapeutic target strategies … P Csermely, J Hódsági, T Korcsmáros, D Módos, ÁR Perez-Lopez, ... Seminars in cancer biology 30, 42-51, 2015 | 78 | 2015 |
| Disordered proteins and network disorder in network descriptions of protein structure, dynamics and function: hypotheses and a comprehensive review P Csermely, K Singh Sandhu, E Hazai, Z Hoksza, H JM Kiss, F Miozzo, ... Current Protein and Peptide Science 13 (1), 19-33, 2012 | 74 | 2012 |
| Network strategies to understand the aging process and help age-related drug design GI Simkó, D Gyurkó, DV Veres, T Nánási, P Csermely Genome medicine 1, 1-7, 2009 | 46 | 2009 |
| Learning of signaling networks: molecular mechanisms P Csermely, N Kunsic, P Mendik, M Kerestély, T Faragó, DV Veres, ... Trends in biochemical sciences 45 (4), 284-294, 2020 | 45 | 2020 |
| Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies DM Gyurkó, DV Veres, D Módos, K Lenti, T Korcsmáros, P Csermely Seminars in Cancer Biology 23 (4), 262-269, 2013 | 40 | 2013 |
| The EntOptLayout Cytoscape plug-in for the efficient visualization of major protein complexes in protein–protein interaction and signalling networks B Ágg, A Császár, M Szalay-Bekő, DV Veres, R Mizsei, P Ferdinandy, ... Bioinformatics 35 (21), 4490-4492, 2019 | 32 | 2019 |
| MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium B Ágg, T Baranyai, A Makkos, B Vető, N Faragó, Á Zvara, Z Giricz, ... Scientific reports 8 (1), 10134, 2018 | 28 | 2018 |
| Translocatome: a novel resource for the analysis of protein translocation between cellular organelles P Mendik, L Dobronyi, F Hári, C Kerepesi, L Maia-Moco, D Buszlai, ... Nucleic Acids Research 47 (D1), D495-D505, 2019 | 17 | 2019 |
| Are rapidly growing cancers more lethal? HO Adami, P Csermely, DV Veres, L Emilsson, M Løberg, M Bretthauer, ... European Journal of Cancer 72, 210-214, 2017 | 13 | 2017 |
| Application of perturbation gene expression profiles in drug discovery—From mechanism of action to quantitative modelling B Szalai, DV Veres Frontiers in Systems Biology 3, 1126044, 2023 | 3 | 2023 |
| Translocating proteins compartment-specifically alter the fate of epithelial-mesenchymal transition in a compartmentalized Boolean network model P Mendik, M Kerestély, S Kamp, D Deritei, N Kunšič, Z Vassy, P Csermely, ... NPJ Systems Biology and Applications 8 (1), 19, 2022 | 2 | 2022 |
| Modular reorganization of signaling networks during the development of colon adenoma and carcinoma K Schulc, ZT Nagy, S Kamp, J Molnár, DV Veres, P Csermely, BM Kovács The Journal of Physical Chemistry B 125 (7), 1716-1726, 2021 | 1 | 2021 |
| Author Correction: MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium B Ágg, T Baranyai, A Makkos, B Vető, N Faragó, Á Zvara, Z Giricz, ... Scientific Reports 8, 2018 | 1 | 2018 |
| Cellular forgetting, desensitisation, stress and ageing in signalling networks. When do cells refuse to learn more? T Veres, M Kerestély, BM Kovács, D Keresztes, K Schulc, E Seitz, Z Vassy, ... Cellular and Molecular Life Sciences 81 (1), 97, 2024 | | 2024 |
| Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors O Papp, V Jordán, S Hetey, R Balázs, V Kaszás, Á Bartha, NN Ordasi, ... npj Systems Biology and Applications 10 (1), 68, 2024 | | 2024 |
| Simulation driven identification of combinations for the WEE1 inhibitor Debio 0123 results in synergistic effect with cabozantinib validated in vivo B Elek, AV Chessex, L Piggott, O Papp, I Fekete, D Veres Cancer Research 84 (6_Supplement), 6507-6507, 2024 | | 2024 |
| 18P NEK1 is a novel cancer target driving tumor growth through altered immune signaling MV Ruiz-Pérez, I Gaspar, I Fekete, C Szántai-Kis, S Connolly, B Elek, ... ESMO Open 9, 2024 | | 2024 |
| Author Correction: Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors O Papp, V Jordán, S Hetey, R Balázs, V Kaszás, Á Bartha, NN Ordasi, ... NPJ Systems Biology and Applications 10, 2024 | | 2024 |
| Combination therapy ÁL Bartha, BF Elek, I Fekete, K Sebestyén, J Kisistók, P Orsolya, D Veres US Patent App. 17/788,786, 2023 | | 2023 |
Peter CsermelySemmelweis University, professor of biochemistry and network scienceE-mail megerősítve itt: med.semmelweis-univ.hu
